In the pharmaceutical domain, counterfeiters, mislabeling of drugs, and fraudulent packaging negatively affect long-term economic growth and have severely damaging impacts on public health. According to one EUIPO report, counterfeit medicines cost the global economy billions of dollars annually, while causing hundreds of thousands of fatalities and adversely affecting countless others.
In this modern commercial landscape, supply chain traceability has emerged as a critical aspect of responsible healthcare practices. By meticulously tracking the production, distribution, and dispensing of pharmaceuticals and medical devices, healthcare strategists can identify and address issues in real-time, mitigating the risk of harm to patients and reducing economic losses. At its core, healthcare supply chain traceability is truly indispensable for complying with regulations and ensuring safety.
The PharmaLedger Association is tackling the issue of healthcare supply chain traceability by proposing an innovative solution, offering analytical tools to patients, healthcare strategists, distributors, and regulatory bodies. Our Supply Chain Traceability approach exemplifies the cutting-edge initiative we are taking toward our current focus; to augment visibility and resilience in the pharmaceutical supply chain.
Through the establishment of this platform, we are facilitating end-to-end traceability across the supply chain, leveraging the concept of product digital twins. This commitment to Supply Chain Traceability is aligned with our broader mission to contribute to a more secure, resilient, and trustworthy Healthcare 4.0.